COVID-19

Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:
Stuart.Needleman@piramal.com

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Debashish Chakravorty  LinkedIn

Executive Vice President, India Formulations

Debashish Chakravorty serves as the Executive Vice President for India formulations at Piramal Pharma Solutions (PPS). In this role, he oversees various sites, including Pithampur in Madhya Pradesh, which focuses on Oral Solid Dosage (OSD) + Form Fill and Seal (FFS) for the Global Market. Additionally, he manages the Mahad site in Maharashtra, specializing in OSD and Vitamins for the Rest of the World (RoW), and handles Development activities for PPDS. Furthermore, Mr. Chakravorty is responsible for the Ahmedabad site in Gujarat, focusing on OSD Development for the Global Market. He is also a board member of Yapan Bio Private Limited, an associate company of Piramal Pharma Limited.

With a techno-commercial understanding of operations, Mr. Chakravorty has held P&L responsibilities for these sites, demonstrating expertise in driving financial growth. He collaborates with customers to ensure the seamless integration of operations from the early stages through life cycle management. With over three decades of association with Piramal, he brings a wealth of experience to his current role.

Prior to his current position, Mr. Chakravorty held a site lead position for Pithampur (PTP) for seven years. He also led Global Business and Strategic Projects for PPS, involving multiple geographies and cultures. A Manufacturing Pharmacist with a background in OSD, he holds an MBA in Finance. 

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer

Herve Berdou    LinkedIn

Chief Operating Officer

Surinder Gulati    LinkedIn

Executive Vice President,
India API and Operations

Manoj Zalpuri    LinkedIn

Executive Vice President, North America Operations

Rashida Najmi    LinkedIn

Chief Quality Officer

Christopher Leahy    LinkedIn

Senior Vice President,
Finance